Histone Deacetylases (HDACs) Guided Novel Therapies for T-cell lymphomas

T-cell lymphomas are a heterogeneous group of cancers with different pathogenesis and poor prognosis. Histone deacetylases (HDACs) are epigenetic modifiers that modulate many key biological processes. In recent years, HDACs have been fully investigated for their roles and potential as drug targets i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qing, Wang, Shaobin, Chen, Junhui, Yu, Zhendong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428980/
https://www.ncbi.nlm.nih.gov/pubmed/30911277
http://dx.doi.org/10.7150/ijms.30154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428980/
https://www.ncbi.nlm.nih.gov/pubmed/30911277
http://dx.doi.org/10.7150/ijms.30154

Ejemplares similares